Skip to content
healthcare.dev

Top Value Effervescent Cold Relief

NDC 50201-7682, Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate, tablet, effervescent, from Tower Laboratories Ltd.

Product NDC
50201-7682
Status
Listed
Labeler
Tower Laboratories Ltd
Dosage form
TABLET, EFFERVESCENT
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50201-7682 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ASPIRIN325 mg/1
  • PHENYLEPHRINE BITARTRATE7.8 mg/1
  • CHLORPHENIRAMINE MALEATE2 mg/1

Pharmacologic classes

Adrenergic alpha1-Agonists [MoA]; Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]; alpha-1 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
50201-7682-25020176820210 POUCH in 1 CARTON (50201-7682-2) / 2 TABLET, EFFERVESCENT in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 50201-7682 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50201-7682 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50201-7682. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.